Clinical Trial

A Study of Weekly Oral Dose of Ecnoglutide (VRB-101) for Weight Maintenance in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities

Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The purpose of this study is to identify the weekly oral dose of VRB-101 (oral ecnoglutide) that can effectively maintain body weight in participants with a history of obesity or overweight with weight-related comorbidities.
Protocol Amendment History 2 changes
critical Trial status changed: Not Yet Recruiting → Active, Not Recruiting 2026-08-05
notable Trial sites expanded: 17 -> 20 locations 2026-08-05
Trial Details
NCT Number NCT07553299
Lead Sponsor Verdiva Bio Dev Limited
Conditions Obesity, Overweight, Weight Maintenance
Enrollment 120 participants
Start Date 2026-06-12
Primary Completion 2026-11-30 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-04